These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 12900067)

  • 1. Evaluation of the French version of EUROQUEST: a questionnaire for neurotoxic symptoms.
    Rouch I; Wild P; Fontana JM; Chouaniere D
    Neurotoxicology; 2003 Aug; 24(4-5):541-6. PubMed ID: 12900067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Euroquest: the validity of a new symptom questionnaire.
    Karlson B; Osterberg K; Orbaek P
    Neurotoxicology; 2000 Oct; 21(5):783-9. PubMed ID: 11130283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptoms of chronic solvent encephalopathy: Euroquest questionnaire study.
    Kaukiainen A; Hyvärinen HK; Akila R; Sainio M
    Neurotoxicology; 2009 Nov; 30(6):1187-94. PubMed ID: 19963103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobehavioral study on the interactive effects of age and solvent exposure.
    Kiesswetter E; Sietmann B; Zupanic M; Seeber A
    Neurotoxicology; 2000 Oct; 21(5):685-95. PubMed ID: 11130272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EUROQUEST--a questionnaire for solvent related symptoms: factor structure, item analysis and predictive validity.
    Carter N; Iregren A; Söderman E; Olson BA; Karlson B; Lindelöf B; Lundberg I; Osterberg K
    Neurotoxicology; 2002 Dec; 23(6):711-7. PubMed ID: 12520761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validity of a computer-assisted neurobehavioral test battery in toxicant encephalopathy.
    Proctor SP; Letz R; White RF
    Neurotoxicology; 2000 Oct; 21(5):703-14. PubMed ID: 11130274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suboptimal performance on neuropsychological tests in patients with suspected chronic toxic encephalopathy.
    van Hout MS; Schmand B; Wekking EM; Hageman G; Deelman BG
    Neurotoxicology; 2003 Aug; 24(4-5):547-51. PubMed ID: 12900068
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subjective symptoms due to solvent mixtures, dioxin, and toluene: impact of exposure versus personality factors.
    Seeber A; Demes P; Golka K; Kiesswetter E; Schäper M; van Thriel C; Zupanic M
    Neurotoxicology; 2000 Oct; 21(5):677-84. PubMed ID: 11130271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence of neurotoxicity in working children in Lebanon.
    Saddik B; Nuwayhid I; Williamson A; Black D
    Neurotoxicology; 2003 Aug; 24(4-5):733-9. PubMed ID: 12900087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Preliminary validation of the French translation of anxiety sensibility index-revised (ASI-R)].
    Bouvard M; Ayxères-Vighetto A; Dupont H; Aupetit J; Portalier S; Arrindell W
    Encephale; 2003; 29(2):157-64. PubMed ID: 14567167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of potential adjustment variables representing primary intellectual level in epidemiological studies on neurotoxicity.
    Rouch I; Chouanière D; Wild P; Fontana JM; Boillat MA
    Am J Ind Med; 2006 Aug; 49(8):642-6. PubMed ID: 16767727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Validation of the French translation of the impulsive nonconformity scale].
    Foullu S; Danet F; Dumas P; Brunelin J; Travart M; Elchardus JM; Saoud M; d'Amato T
    Encephale; 2008 Dec; 34(6):563-9. PubMed ID: 19081452
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Switching attention--additional aspects for the analysis.
    van Thriel C; Kleinsorge T; Zupanic M; Seeber A
    Neurotoxicology; 2000 Oct; 21(5):795-804. PubMed ID: 11130285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcultural adaptation and validation of the Spanish version of EUROQUEST.
    Marhuenda D; Prieto MJ; Cardona A; Roel JM; Oliveras MA
    Neurologia; 2015 May; 30(4):201-7. PubMed ID: 24480593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detecting chronic solvent encephalopathy in occupations at risk.
    Furu H; Sainio M; Hyvärinen HK; Akila R; Bäck B; Uuksulainen S; Kaukiainen A
    Neurotoxicology; 2012 Aug; 33(4):734-41. PubMed ID: 22560996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neurobehavioral disturbances arising from occupational toluene exposure.
    Chouanière D; Wild P; Fontana JM; Héry M; Fournier M; Baudin V; Subra I; Rousselle D; Toamain JP; Saurin S; Ardiot MR
    Am J Ind Med; 2002 Feb; 41(2):77-88. PubMed ID: 11813212
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pain coping strategies: French adaptation of the coping strategies questionnaire (CSQ-F)].
    Irachabal S; Koleck M; Rascle N; Bruchon-Schweitzer M
    Encephale; 2008 Jan; 34(1):47-53. PubMed ID: 18514150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The development and validation of a carer questionnaire to assess cognitive function in neuropsychiatric patients.
    Randhawa S; Walterfang M; Miller K; Scholes A; Mocellin R; Velakoulis D
    J Psychosom Res; 2007 Jul; 63(1):93-8. PubMed ID: 17586342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of occupational neurobehavioural hazards. Methodological experiences from organic solvent research.
    Hogstedt C; Lundberg I
    Rev Epidemiol Sante Publique; 1992; 40 Suppl 1():S7-16. PubMed ID: 1626108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.